TY - JOUR
T1 - TFOS DEWS II iatrogenic report
AU - Gomes, José Alvaro P.
AU - Azar, Dimitri T.
AU - Baudouin, Christophe
AU - Efron, Nathan
AU - Hirayama, Masatoshi
AU - Horwath-Winter, Jutta
AU - Kim, Terry
AU - Mehta, Jodhbir S.
AU - Messmer, Elisabeth M.
AU - Pepose, Jay S.
AU - Sangwan, Virender S.
AU - Weiner, Alan L.
AU - Wilson, Steven E.
AU - Wolffsohn, James S.
PY - 2017/7
Y1 - 2017/7
N2 - Dry eye can be caused by a variety of iatrogenic interventions. The increasing number of patients looking for eye care or cosmetic procedures involving the eyes, together with a better understanding of the pathophysiological mechanisms of dry eye disease (DED), have led to the need of a specific report about iatrogenic dry eye within the TFOS DEWS II.Topical medications can cause DED due to their allergic, toxic and immuno-inflammatory effects on the ocular surface. Preservatives, such as benzalkonium chloride, may further aggravate DED. A variety of systemic drugs can also induce DED secondary to multiple mechanisms. Moreover, the use of contact lens induces or is associated with DED. However, one of the most emblematic situations is DED caused by surgical procedures such as corneal refractive surgery as in laser-assisted in situ keratomileusis (LASIK) and keratoplasty due to mechanisms intrinsic to the procedure (i.e. corneal nerve cutting) or even by the use of postoperative topical drugs. Cataract surgery, lid surgeries, botulinum toxin application and cosmetic procedures are also considered risk factors to iatrogenic DED, which can cause patients' dissatisfaction, visual disturbances and poor surgical outcomes.This report also presents future directions to address iatrogenic DED, including the need of deeper epidemiological studies about the risk factors, development of less toxic medications and preservatives, as well as new techniques for less invasive eye surgeries. Novel research into detection of early dry eye prior to surgeries, efforts to establish appropriate therapeutics and a greater attempt to regulate and oversee medications, preservatives and procedures should be considered.
AB - Dry eye can be caused by a variety of iatrogenic interventions. The increasing number of patients looking for eye care or cosmetic procedures involving the eyes, together with a better understanding of the pathophysiological mechanisms of dry eye disease (DED), have led to the need of a specific report about iatrogenic dry eye within the TFOS DEWS II.Topical medications can cause DED due to their allergic, toxic and immuno-inflammatory effects on the ocular surface. Preservatives, such as benzalkonium chloride, may further aggravate DED. A variety of systemic drugs can also induce DED secondary to multiple mechanisms. Moreover, the use of contact lens induces or is associated with DED. However, one of the most emblematic situations is DED caused by surgical procedures such as corneal refractive surgery as in laser-assisted in situ keratomileusis (LASIK) and keratoplasty due to mechanisms intrinsic to the procedure (i.e. corneal nerve cutting) or even by the use of postoperative topical drugs. Cataract surgery, lid surgeries, botulinum toxin application and cosmetic procedures are also considered risk factors to iatrogenic DED, which can cause patients' dissatisfaction, visual disturbances and poor surgical outcomes.This report also presents future directions to address iatrogenic DED, including the need of deeper epidemiological studies about the risk factors, development of less toxic medications and preservatives, as well as new techniques for less invasive eye surgeries. Novel research into detection of early dry eye prior to surgeries, efforts to establish appropriate therapeutics and a greater attempt to regulate and oversee medications, preservatives and procedures should be considered.
KW - contact lens
KW - cosmetic
KW - drug related adverse reactions
KW - drug related side effects
KW - drug toxicity
KW - dry eye
KW - iatrogenic disease
KW - surgery
UR - http://www.scopus.com/inward/record.url?scp=85025689545&partnerID=8YFLogxK
U2 - 10.1016/j.jtos.2017.05.004
DO - 10.1016/j.jtos.2017.05.004
M3 - Article
AN - SCOPUS:85025689545
SN - 1542-0124
VL - 15
SP - 511
EP - 538
JO - Ocular Surface
JF - Ocular Surface
IS - 3
ER -